Literature DB >> 10632009

Study of the first contact management profile of cases of infectious keratitis: a hospital-based study.

R B Vajpayee1, T Dada, R Saxena, M Vajpayee, H R Taylor, P Venkatesh, N Sharma.   

Abstract

PURPOSE: To study the management pattern and examine the role of cultures and antibiotic sensitivity testing in infectious keratitis.
METHODS: A retrospective analysis of the demographic, clinical, and microbiological data was performed in 100 consecutive patients with infectious keratitis. The main parameters evaluated were nature of first contact with the health care services, investigations undertaken, treatment initiated, and the time interval between presentation to the first medical contact and to our center. Finally, the reports of culture and antibiotic sensitivity testing undertaken at our center were evaluated.
RESULTS: In 70% of cases, ophthalmologists in independent practice were the first medical contact. Direct microscopy of the corneal scraping was undertaken in only 6% of cases, whereas culture and sensitivity studies had not been performed in any of the patients. Forty-six percent of the patients were prescribed 0.3% ciprofloxacin eyedrops in an inadequate dosage. Broad-spectrum fortified antibiotics eye drops had not been prescribed in any of the cases. At our center, positive cultures were obtained in 73.86% of cases and the most common organism isolated was coagulase-negative Staphylococcus (33.84%), followed by Pseudomonas aeruginosa (15.38%). A large number of the isolates demonstrated resistance to the recommended antibiotic therapy.
CONCLUSIONS: Failure to implement standard management protocol for infectious keratitis at first contact is a major factor contributing to ocular morbidity in India.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632009     DOI: 10.1097/00003226-200001000-00011

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  24 in total

1.  Epidemiological, clinical and laboratory findings of infectious keratitis at Mansoura Ophthalmic Center, Egypt.

Authors:  Amani E Badawi; Dalia Moemen; Nora L El-Tantawy
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

2.  [Microbial keratitis: a 4 year study of risk factors and traditional/complementary medicine in Oman].

Authors:  A Bialasiewicz; R Shenoy; A Thakral; A A Al-Muniri; U Shenoy; Z Al-Mughairi
Journal:  Ophthalmologe       Date:  2006-08       Impact factor: 1.059

Review 3.  The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance.

Authors:  Lawson Ung; Paulo J M Bispo; Swapna S Shanbhag; Michael S Gilmore; James Chodosh
Journal:  Surv Ophthalmol       Date:  2018-12-24       Impact factor: 6.048

Review 4.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Bacterial keratitis: a prospective clinical and microbiological study.

Authors:  F Schaefer; O Bruttin; L Zografos; Y Guex-Crosier
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

6.  Risk factors for perforation in microbial corneal ulcers in north India.

Authors:  J S Titiyal; S Negi; A Anand; R Tandon; N Sharma; R B Vajpayee
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

7.  Ciprofloxacin susceptibility of Pseudomonas aeruginosa isolates from keratitis.

Authors:  J A Lomholt; M Kilian
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

8.  Non-viral microbial keratitis in children.

Authors:  Abdullah G Al-Otaibi
Journal:  Saudi J Ophthalmol       Date:  2011-10-13

Review 9.  Topical corticosteroids as adjunctive therapy for bacterial keratitis.

Authors:  O Suwan-Apichon; J M Reyes; S Herretes; S S Vedula; R S Chuck
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.

Authors:  T Bourcier; F Thomas; V Borderie; C Chaumeil; L Laroche
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.